发明名称 Method of reducing total cholesterol level by administering matrilin-2 polypeptide
摘要 The present invention provides, in part, methods and compositions for treating lipid disorders comprising administering a polypeptide that inhibits PCSK9. A novel method for identifying polypeptides that interact with PCSK9 is also provided.
申请公布号 US9089522(B2) 申请公布日期 2015.07.28
申请号 US200912993672 申请日期 2009.05.21
申请人 Merck Sharp & Dohme Corp. 发明人 Zhang Qing;Murgolo Nicholas J.;Hedrick Joseph A.
分类号 A61K38/17;A61K47/48;A61K31/366;A61K31/397;A61K38/39;A61K45/06;C07K14/78;G01N33/573 主分类号 A61K38/17
代理机构 代理人 Thampoe Immac J.;Su Li
主权项 1. A method for reducing total cholesterol level, low density lipoprotein cholesterol level, apolipoprotein B level, total cholesterol/high density lipoprotein ratio or low density lipoprotein/high density lipoprotein ratio, comprising administering to a patient with a disorder of cholesterol or lipid homeostasis, a therapeutically effective amount of a composition comprising matrilin-2 polypeptide comprising the amino acid sequence selected from the group consisting of SEQ ID NO: 1, amino acids 24-956 of SEQ ID NO: 2 and SEQ ID NO: 2.
地址 Rahway NJ US